| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxidative Stress | 26 | 2024 | 870 | 5.810 |
Why?
|
| Refugees | 5 | 2024 | 31 | 4.080 |
Why?
|
| Stress, Psychological | 13 | 2022 | 600 | 3.470 |
Why?
|
| Anxiety | 19 | 2021 | 992 | 3.190 |
Why?
|
| Maze Learning | 14 | 2024 | 130 | 2.580 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2024 | 644 | 2.360 |
Why?
|
| Vitis | 5 | 2017 | 16 | 2.330 |
Why?
|
| Memory Disorders | 12 | 2024 | 235 | 2.010 |
Why?
|
| Sleep Deprivation | 4 | 2019 | 55 | 2.000 |
Why?
|
| Vehicle Emissions | 3 | 2021 | 20 | 1.930 |
Why?
|
| Neuroprotective Agents | 4 | 2024 | 167 | 1.910 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2021 | 1306 | 1.840 |
Why?
|
| Rats | 31 | 2024 | 3879 | 1.690 |
Why?
|
| Hippocampus | 9 | 2024 | 862 | 1.650 |
Why?
|
| Antioxidants | 8 | 2024 | 378 | 1.590 |
Why?
|
| Behavior, Animal | 10 | 2021 | 522 | 1.570 |
Why?
|
| Cyclic N-Oxides | 4 | 2016 | 29 | 1.560 |
Why?
|
| Rats, Wistar | 13 | 2024 | 400 | 1.510 |
Why?
|
| Corticosterone | 12 | 2021 | 61 | 1.440 |
Why?
|
| Hypertension | 6 | 2020 | 1391 | 1.410 |
Why?
|
| Memory | 4 | 2024 | 358 | 1.380 |
Why?
|
| Plant Extracts | 3 | 2017 | 140 | 1.300 |
Why?
|
| Air Pollutants | 2 | 2021 | 113 | 1.130 |
Why?
|
| Brain | 11 | 2021 | 3217 | 1.120 |
Why?
|
| Animals | 51 | 2024 | 36364 | 1.040 |
Why?
|
| Physical Conditioning, Animal | 5 | 2017 | 100 | 1.030 |
Why?
|
| Dominance-Subordination | 5 | 2017 | 11 | 0.970 |
Why?
|
| Motor Activity | 5 | 2017 | 537 | 0.960 |
Why?
|
| Pentoxifylline | 1 | 2024 | 20 | 0.920 |
Why?
|
| Aging | 4 | 2017 | 1304 | 0.920 |
Why?
|
| RGS Proteins | 4 | 2015 | 47 | 0.890 |
Why?
|
| Mental Disorders | 4 | 2024 | 878 | 0.880 |
Why?
|
| beta-Adrenergic Receptor Kinases | 4 | 2007 | 26 | 0.880 |
Why?
|
| Disease Models, Animal | 15 | 2017 | 4772 | 0.860 |
Why?
|
| Inflammation | 6 | 2019 | 1595 | 0.850 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 151 | 0.840 |
Why?
|
| Syria | 4 | 2024 | 9 | 0.840 |
Why?
|
| Mitochondria | 4 | 2020 | 743 | 0.830 |
Why?
|
| Social Class | 1 | 2024 | 205 | 0.830 |
Why?
|
| Aggression | 2 | 2015 | 232 | 0.820 |
Why?
|
| Buthionine Sulfoximine | 4 | 2016 | 28 | 0.780 |
Why?
|
| Brain-Derived Neurotrophic Factor | 7 | 2014 | 122 | 0.780 |
Why?
|
| Students | 2 | 2021 | 261 | 0.770 |
Why?
|
| Rats, Long-Evans | 6 | 2020 | 105 | 0.750 |
Why?
|
| Sex Characteristics | 2 | 2021 | 335 | 0.740 |
Why?
|
| Lactoylglutathione Lyase | 7 | 2017 | 12 | 0.730 |
Why?
|
| Superoxide Dismutase | 6 | 2024 | 187 | 0.730 |
Why?
|
| Academic Success | 1 | 2021 | 24 | 0.720 |
Why?
|
| Propranolol | 2 | 2020 | 130 | 0.700 |
Why?
|
| Memory, Short-Term | 5 | 2015 | 148 | 0.690 |
Why?
|
| Male | 37 | 2024 | 65815 | 0.670 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 525 | 0.670 |
Why?
|
| Nadolol | 1 | 2020 | 29 | 0.660 |
Why?
|
| Jordan | 3 | 2024 | 8 | 0.650 |
Why?
|
| Mitochondrial Dynamics | 1 | 2020 | 54 | 0.640 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2020 | 253 | 0.640 |
Why?
|
| Mental Health | 2 | 2024 | 372 | 0.610 |
Why?
|
| Neurons | 5 | 2021 | 2034 | 0.590 |
Why?
|
| Dinoprost | 5 | 2021 | 31 | 0.580 |
Why?
|
| Resilience, Psychological | 2 | 2017 | 73 | 0.580 |
Why?
|
| Health Impact Assessment | 1 | 2017 | 1 | 0.570 |
Why?
|
| Anxiety Disorders | 2 | 2014 | 725 | 0.560 |
Why?
|
| Neural Pathways | 1 | 2019 | 285 | 0.560 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 262 | 0.550 |
Why?
|
| Social Perception | 1 | 2017 | 59 | 0.540 |
Why?
|
| Visual Perception | 2 | 2017 | 135 | 0.540 |
Why?
|
| Maternal Behavior | 1 | 2017 | 71 | 0.540 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 97 | 0.530 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 115 | 0.520 |
Why?
|
| Air Pollution | 1 | 2017 | 75 | 0.520 |
Why?
|
| Mood Disorders | 1 | 2017 | 128 | 0.510 |
Why?
|
| Catecholamines | 2 | 2021 | 59 | 0.500 |
Why?
|
| Glutathione Reductase | 5 | 2013 | 13 | 0.490 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 388 | 0.490 |
Why?
|
| Fruit | 2 | 2015 | 237 | 0.470 |
Why?
|
| Phytotherapy | 1 | 2015 | 53 | 0.470 |
Why?
|
| Plant Preparations | 1 | 2014 | 18 | 0.460 |
Why?
|
| Spin Labels | 4 | 2016 | 39 | 0.450 |
Why?
|
| Central Nervous System | 1 | 2016 | 286 | 0.450 |
Why?
|
| Adenylyl Cyclases | 2 | 2004 | 89 | 0.420 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 44 | 0.410 |
Why?
|
| Pandemics | 1 | 2021 | 1196 | 0.400 |
Why?
|
| Cognition Disorders | 1 | 2017 | 579 | 0.400 |
Why?
|
| Carbohydrate Metabolism | 3 | 2007 | 58 | 0.400 |
Why?
|
| Glutathione | 3 | 2024 | 201 | 0.390 |
Why?
|
| Depression | 6 | 2017 | 1349 | 0.390 |
Why?
|
| Lipid Peroxidation | 2 | 2024 | 99 | 0.390 |
Why?
|
| Social Behavior | 1 | 2014 | 230 | 0.390 |
Why?
|
| Random Allocation | 4 | 2020 | 450 | 0.380 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2011 | 19 | 0.370 |
Why?
|
| Spatial Memory | 2 | 2024 | 33 | 0.370 |
Why?
|
| Estrogens | 1 | 2013 | 521 | 0.350 |
Why?
|
| Islam | 2 | 2007 | 11 | 0.350 |
Why?
|
| Powders | 3 | 2015 | 28 | 0.340 |
Why?
|
| Kidney | 4 | 2020 | 1410 | 0.340 |
Why?
|
| Depressive Disorder | 1 | 2014 | 484 | 0.330 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 3738 | 0.330 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 2764 | 0.330 |
Why?
|
| Exercise Test | 2 | 2013 | 267 | 0.330 |
Why?
|
| Cognition | 1 | 2014 | 815 | 0.310 |
Why?
|
| Fasting | 2 | 2007 | 310 | 0.310 |
Why?
|
| Blotting, Western | 6 | 2011 | 1134 | 0.290 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 3987 | 0.280 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 2656 | 0.280 |
Why?
|
| Religion and Medicine | 1 | 2007 | 25 | 0.280 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 4 | 2003 | 9 | 0.270 |
Why?
|
| Oxygen Consumption | 2 | 2020 | 316 | 0.270 |
Why?
|
| Humans | 22 | 2024 | 133854 | 0.270 |
Why?
|
| Amyloid beta-Peptides | 4 | 2013 | 243 | 0.270 |
Why?
|
| Female | 11 | 2024 | 71586 | 0.270 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 38 | 0.260 |
Why?
|
| Homeostasis | 1 | 2011 | 748 | 0.260 |
Why?
|
| Housing, Animal | 2 | 2017 | 18 | 0.260 |
Why?
|
| Diet | 1 | 2013 | 1196 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 260 | 0.240 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 5 | 2011 | 11 | 0.240 |
Why?
|
| Insulin Resistance | 1 | 2010 | 684 | 0.240 |
Why?
|
| Streptozocin | 1 | 2024 | 28 | 0.230 |
Why?
|
| Glutathione Peroxidase | 1 | 2024 | 54 | 0.230 |
Why?
|
| Aerosols | 1 | 2024 | 66 | 0.230 |
Why?
|
| Vitamin E | 1 | 2024 | 69 | 0.230 |
Why?
|
| Exploratory Behavior | 2 | 2017 | 55 | 0.220 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2024 | 14 | 0.220 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2024 | 58 | 0.210 |
Why?
|
| Darkness | 2 | 2015 | 26 | 0.210 |
Why?
|
| Educational Status | 1 | 2024 | 293 | 0.210 |
Why?
|
| Texas | 2 | 2022 | 3684 | 0.200 |
Why?
|
| Time Factors | 6 | 2015 | 6584 | 0.200 |
Why?
|
| Stress, Physiological | 2 | 2015 | 271 | 0.200 |
Why?
|
| Amygdala | 2 | 2015 | 87 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2011 | 4898 | 0.200 |
Why?
|
| Long-Term Potentiation | 3 | 2013 | 163 | 0.190 |
Why?
|
| Brain Chemistry | 2 | 2013 | 125 | 0.190 |
Why?
|
| Alzheimer Disease | 4 | 2013 | 875 | 0.190 |
Why?
|
| Microvilli | 4 | 2007 | 72 | 0.190 |
Why?
|
| Bromine | 1 | 2021 | 5 | 0.180 |
Why?
|
| Cell Line | 3 | 2016 | 2837 | 0.180 |
Why?
|
| Epinephrine | 3 | 2014 | 182 | 0.180 |
Why?
|
| Xanthine | 2 | 2011 | 7 | 0.180 |
Why?
|
| Cell Survival | 2 | 2016 | 891 | 0.180 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 218 | 0.180 |
Why?
|
| Xanthine Oxidase | 2 | 2011 | 42 | 0.180 |
Why?
|
| Models, Animal | 3 | 2015 | 483 | 0.180 |
Why?
|
| Health Status | 1 | 2023 | 412 | 0.170 |
Why?
|
| Histones | 2 | 2014 | 568 | 0.170 |
Why?
|
| Brain Stem | 1 | 2021 | 121 | 0.170 |
Why?
|
| Faculty | 1 | 2021 | 108 | 0.170 |
Why?
|
| Analysis of Variance | 3 | 2013 | 1046 | 0.170 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 38 | 0.170 |
Why?
|
| Perception | 1 | 2022 | 234 | 0.170 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 28 | 0.170 |
Why?
|
| Universities | 1 | 2021 | 130 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2024 | 1193 | 0.170 |
Why?
|
| Carrier Proteins | 3 | 2000 | 1066 | 0.170 |
Why?
|
| Teaching | 1 | 2021 | 200 | 0.160 |
Why?
|
| Superoxides | 1 | 2020 | 130 | 0.160 |
Why?
|
| Nitric Oxide Synthase | 1 | 2020 | 177 | 0.160 |
Why?
|
| Locus Coeruleus | 2 | 2011 | 21 | 0.160 |
Why?
|
| Calpain | 2 | 2011 | 43 | 0.150 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 2 | 2011 | 5 | 0.150 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 773 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 413 | 0.150 |
Why?
|
| Young Adult | 2 | 2024 | 9885 | 0.150 |
Why?
|
| Locomotion | 1 | 2019 | 69 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2021 | 338 | 0.150 |
Why?
|
| Estradiol | 1 | 2021 | 551 | 0.150 |
Why?
|
| Up-Regulation | 4 | 2013 | 905 | 0.150 |
Why?
|
| CA1 Region, Hippocampal | 3 | 2013 | 80 | 0.140 |
Why?
|
| Drinking | 1 | 2017 | 35 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2013 | 1411 | 0.140 |
Why?
|
| Gene Expression | 2 | 2013 | 1614 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2022 | 1485 | 0.140 |
Why?
|
| Psychological Tests | 1 | 2017 | 94 | 0.140 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 169 | 0.140 |
Why?
|
| Kidney Cortex | 4 | 2007 | 20 | 0.140 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 229 | 0.140 |
Why?
|
| Phosphates | 3 | 2007 | 119 | 0.140 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2024 | 312 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1326 | 0.130 |
Why?
|
| Isoprostanes | 1 | 2015 | 3 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 48 | 0.130 |
Why?
|
| Cell Shape | 1 | 2016 | 70 | 0.130 |
Why?
|
| Mice | 5 | 2024 | 18884 | 0.130 |
Why?
|
| Postpartum Period | 1 | 2017 | 227 | 0.120 |
Why?
|
| Immune System | 1 | 2016 | 98 | 0.120 |
Why?
|
| Equipment Design | 1 | 2017 | 613 | 0.120 |
Why?
|
| Memory, Long-Term | 1 | 2015 | 40 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 607 | 0.120 |
Why?
|
| Animals, Newborn | 1 | 2019 | 1045 | 0.120 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 109 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2022 | 894 | 0.120 |
Why?
|
| Infusion Pumps | 1 | 2015 | 34 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 295 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2015 | 59 | 0.120 |
Why?
|
| Adolescent | 2 | 2024 | 20517 | 0.110 |
Why?
|
| Protein Carbonylation | 2 | 2011 | 8 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2014 | 175 | 0.110 |
Why?
|
| Neuroimmunomodulation | 1 | 2014 | 15 | 0.110 |
Why?
|
| Anhedonia | 1 | 2014 | 36 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 122 | 0.110 |
Why?
|
| Cell Membrane | 3 | 2006 | 486 | 0.110 |
Why?
|
| Social Dominance | 1 | 2013 | 11 | 0.110 |
Why?
|
| Acetylation | 1 | 2014 | 183 | 0.110 |
Why?
|
| Deoxyguanosine | 1 | 2013 | 13 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 407 | 0.110 |
Why?
|
| Food, Preserved | 1 | 2013 | 2 | 0.110 |
Why?
|
| Emotions | 1 | 2016 | 366 | 0.100 |
Why?
|
| Freeze Drying | 1 | 2013 | 16 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 286 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2013 | 47 | 0.100 |
Why?
|
| Polyphenols | 1 | 2013 | 25 | 0.100 |
Why?
|
| Body Weight | 1 | 2017 | 1034 | 0.100 |
Why?
|
| Ovariectomy | 1 | 2013 | 188 | 0.100 |
Why?
|
| Dopamine | 1 | 2014 | 284 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 2785 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 109 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 2004 | 262 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 149 | 0.100 |
Why?
|
| Learning | 2 | 2013 | 377 | 0.100 |
Why?
|
| Adult | 2 | 2024 | 31925 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 2004 | 3970 | 0.090 |
Why?
|
| DNA, Antisense | 1 | 2011 | 9 | 0.090 |
Why?
|
| Predatory Behavior | 1 | 2011 | 10 | 0.090 |
Why?
|
| Amnesia | 1 | 2011 | 18 | 0.090 |
Why?
|
| Oxidants | 1 | 2011 | 34 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2011 | 644 | 0.090 |
Why?
|
| Helplessness, Learned | 1 | 2011 | 8 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 64 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 129 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 3751 | 0.090 |
Why?
|
| Biomarkers | 3 | 2021 | 3422 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 130 | 0.090 |
Why?
|
| Light | 1 | 2011 | 187 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2011 | 151 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2007 | 2902 | 0.080 |
Why?
|
| Kidney Medulla | 2 | 2007 | 19 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 983 | 0.080 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 18 | 0.080 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 111 | 0.080 |
Why?
|
| Ischemia | 3 | 2005 | 383 | 0.080 |
Why?
|
| Malondialdehyde | 1 | 2010 | 62 | 0.080 |
Why?
|
| Ganglionic Stimulants | 1 | 2009 | 11 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2013 | 498 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 866 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2007 | 3167 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2011 | 453 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 707 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 755 | 0.070 |
Why?
|
| Nicotine | 1 | 2009 | 147 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2011 | 717 | 0.070 |
Why?
|
| Biological Transport, Active | 1 | 2007 | 89 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2013 | 174 | 0.070 |
Why?
|
| Transcription Factor AP-2 | 1 | 2007 | 23 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2004 | 633 | 0.070 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2007 | 64 | 0.070 |
Why?
|
| Benzophenanthridines | 1 | 2007 | 2 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 45 | 0.070 |
Why?
|
| Phentolamine | 1 | 2007 | 20 | 0.070 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2007 | 58 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2021 | 55 | 0.070 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2007 | 24 | 0.070 |
Why?
|
| Ionomycin | 1 | 2006 | 19 | 0.070 |
Why?
|
| Benzoquinones | 1 | 2006 | 19 | 0.070 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 19 | 0.070 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 39 | 0.070 |
Why?
|
| Enzyme Stability | 1 | 2006 | 60 | 0.070 |
Why?
|
| Alkaloids | 1 | 2007 | 37 | 0.070 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2007 | 27 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2007 | 94 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 204 | 0.060 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2007 | 65 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 433 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2003 | 231 | 0.060 |
Why?
|
| Kinetics | 3 | 2005 | 1355 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 290 | 0.060 |
Why?
|
| Binding Sites | 3 | 2003 | 1371 | 0.060 |
Why?
|
| United States | 1 | 2021 | 11682 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 124 | 0.060 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 2004 | 3 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2006 | 317 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2004 | 21 | 0.050 |
Why?
|
| Middle Aged | 1 | 2024 | 29371 | 0.050 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2003 | 6 | 0.050 |
Why?
|
| Proteinuria | 1 | 2024 | 113 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2003 | 312 | 0.050 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2006 | 48 | 0.050 |
Why?
|
| Adenylyl Cyclase Inhibitors | 1 | 2003 | 11 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 98 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2006 | 104 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 34 | 0.050 |
Why?
|
| Calcineurin | 2 | 2013 | 101 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17457 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 730 | 0.050 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2021 | 34 | 0.050 |
Why?
|
| Electric Stimulation | 2 | 2013 | 326 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2003 | 259 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2021 | 115 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2024 | 466 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2021 | 187 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 149 | 0.040 |
Why?
|
| Acyl Coenzyme A | 1 | 2000 | 25 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2000 | 29 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 312 | 0.040 |
Why?
|
| Synaptic Transmission | 2 | 2013 | 369 | 0.040 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 1999 | 17 | 0.040 |
Why?
|
| Liver | 1 | 2006 | 1867 | 0.040 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 2 | 2011 | 16 | 0.040 |
Why?
|
| Reperfusion | 3 | 2005 | 29 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 465 | 0.040 |
Why?
|
| Metabolome | 1 | 2021 | 312 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 913 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2527 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 13011 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2021 | 722 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4800 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4532 | 0.030 |
Why?
|
| Apoptosis | 1 | 1999 | 1931 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 234 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 438 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2009 | 38 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 62 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 833 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2009 | 159 | 0.020 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2006 | 3 | 0.020 |
Why?
|
| Leucyl Aminopeptidase | 1 | 2006 | 3 | 0.020 |
Why?
|
| Malate Dehydrogenase | 1 | 2006 | 5 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 2006 | 9 | 0.020 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2006 | 18 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1702 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2006 | 67 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2006 | 27 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2006 | 11 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2005 | 72 | 0.020 |
Why?
|
| Phosphorus | 1 | 2005 | 61 | 0.010 |
Why?
|
| Proline | 1 | 2005 | 80 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2005 | 71 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 370 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 292 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 387 | 0.010 |
Why?
|
| Renal Circulation | 1 | 2004 | 46 | 0.010 |
Why?
|
| Sodium | 1 | 2005 | 307 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 1089 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2004 | 103 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 283 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 249 | 0.010 |
Why?
|
| Steroids | 1 | 2003 | 210 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1836 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1136 | 0.010 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 1999 | 4 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 99 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 837 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 676 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 228 | 0.010 |
Why?
|
| Phospholipids | 1 | 1997 | 113 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 423 | 0.010 |
Why?
|
| Cholesterol | 1 | 1997 | 574 | 0.010 |
Why?
|